Suswapna Singh Rawat: The Role of Platelets in Heart Disease and Antiplatelet Therapy
Suswapna Singh Rawat, Physician, shared a post on LinkedIn:
“Platelets play a crucial role in managing ruptures within blood vessels and contributing to blockages in smaller vessels.
While they are essential for clotting, in cases of established heart disease, stents, or bypasses, reducing their activity becomes vital.
Antiplatelet medications like aspirin, clopidogrel, dipyridamole, and ticagrelor are instrumental in these scenarios.
They work by making blood less prone to clotting and aggregation, thereby easing passage through blockages.
For individuals without existing heart conditions, platelets have a less pronounced role, but for those with diagnosed heart disease or recent interventions, these medications are critical.
Management of heart disease is multifactorial, involving measures to reduce blood pressure, inflammation, and LDL cholesterol, alongside controlling platelet activity.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026